# Immune-Onc Therapeutics, Inc.: funding, H-1B (2023)

Registers read on November 19, 2026.

Immune-Onc Therapeutics, Inc. (California) appears in 3 public registers SpecStream reads: 1 Form D filing, 1 certified H-1B or PERM case and 1 NIH or NSF award; the newest record is dated March 6, 2023, and the registers were read on November 19, 2026.

SpecStream is the live web data engine for teams and agents. This page joins the public registers SpecStream already reads for one company.

- Registers: 3
- Newest record: March 6, 2023
- State: California

## Form D filings (SEC)

1 Form D filing, newest September 21, 2016.

| Record | Date | Detail | Source |
| --- | --- | --- | --- |
| [Form D](https://specstream.ai/data/form-d/company/immune-onc-therapeutics-inc-1685307) | September 21, 2016 | $7 million sold of $7 million offered; Biotechnology | [sec.gov](https://www.sec.gov/Archives/edgar/data/1685307/000168530716000001/0001685307-16-000001-index.htm) |

- [Immune-Onc Therapeutics, Inc.](https://specstream.ai/data/form-d/company/immune-onc-therapeutics-inc-1685307)
- [SEC EDGAR filings](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1685307&type=D)

## H-1B and PERM certifications (Department of Labor)

1 certified H-1B or PERM case, newest March 6, 2023.

| Record | Date | Detail | Source |
| --- | --- | --- | --- |
| [Associate Scientist, Antibody Engineering](https://specstream.ai/data/hiring/employer/immune-onc-therapeutics-inc-palo-alto-ca) | March 6, 2023 | H-1B, 1 case, $113 thousand offered | [dol.gov](https://www.dol.gov/sites/dolgov/files/ETA/oflc/pdfs/LCA_Disclosure_Data_FY2023_Q2.xlsx) |

- [Immune-Onc Therapeutics, Inc.](https://specstream.ai/data/hiring/employer/immune-onc-therapeutics-inc-palo-alto-ca)

## NIH and NSF research awards

1 NIH or NSF award, newest August 1, 2020.

| Record | Date | Detail | Source |
| --- | --- | --- | --- |
| [NIH](https://specstream.ai/data/research-funding/organization/immune-onc-therapeutics-inc-ipf10052951) | August 1, 2020 | Non-clinical Combination Pharmacology Studies and Phase 1 Clinical Development of IO-202 in Acute Myeloid Leukemia (AML); $1.1 million | [reporter.nih.gov](https://reporter.nih.gov/project-details/10224918) |

- [Immune-Onc Therapeutics, Inc.](https://specstream.ai/data/research-funding/organization/immune-onc-therapeutics-inc-ipf10052951)

## How these records were matched

Records are joined when they carry the same SEC CIK, EIN or UEI, or when their legal names match word for word, legal form aside, at an address in the same state (California), and no register gives a second identifier, a second headquarters or a second filer of that name. Each record links to its own page and to the agency that published it.

Source: the registers named in each section. Public records of US federal and state agencies.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in California

- [Energy companies in California, United States](https://specstream.ai/data/businesses/energy-companies/california-united-states)
- [Tex-Mex restaurants in California, United States](https://specstream.ai/data/businesses/tex-mex-restaurants/california-united-states)
- [Home security companies in California, United States](https://specstream.ai/data/businesses/home-security-companies/california-united-states)
- [American restaurants in California, United States](https://specstream.ai/data/businesses/american-restaurants/california-united-states)
- [Maternity centers in California, United States](https://specstream.ai/data/businesses/maternity-centers/california-united-states)
- [Business law firms in California, United States](https://specstream.ai/data/businesses/business-law-firms/california-united-states)
